Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia

INTRODUCTION: Hyperinsulinism associated with Beckwith-Wiedemann syndrome (BWS) can occur in about 50% of cases, causing hypoglycemia of variable severity. Parenteral use of octreotide may be indicated if unresponsive to diazoxide. There is limited data on use of octreotide in BWS. OBJECTIVE: Chart...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Zubeidi, Hiba, Gottschalk, Michael E, Newfield, Ron S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168987/
https://www.ncbi.nlm.nih.gov/pubmed/25243012
http://dx.doi.org/10.1186/1687-9856-2014-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168987/
https://www.ncbi.nlm.nih.gov/pubmed/25243012
http://dx.doi.org/10.1186/1687-9856-2014-18

Ejemplares similares